Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to -$2.5 million.

  • Beauty Health's Change in Receivables rose 1267.11% to -$2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year increase of 4876.58%. This contributed to the annual value of -$20.8 million for FY2024, which is 2593.22% down from last year.
  • As of Q3 2025, Beauty Health's Change in Receivables stood at -$2.5 million, which was up 1267.11% from $1.7 million recorded in Q2 2025.
  • Beauty Health's 5-year Change in Receivables high stood at $20.3 million for Q2 2022, and its period low was -$10.5 million during Q4 2023.
  • Moreover, its 5-year median value for Change in Receivables was -$2.8 million (2024), whereas its average is $1.1 million.
  • Per our database at Business Quant, Beauty Health's Change in Receivables skyrocketed by 377655.37% in 2021 and then tumbled by 19879.42% in 2023.
  • Quarter analysis of 5 years shows Beauty Health's Change in Receivables stood at $13.7 million in 2021, then plummeted by 162.7% to -$8.6 million in 2022, then fell by 22.17% to -$10.5 million in 2023, then rose by 29.08% to -$7.5 million in 2024, then soared by 66.63% to -$2.5 million in 2025.
  • Its Change in Receivables was -$2.5 million in Q3 2025, compared to $1.7 million in Q2 2025 and -$4.0 million in Q1 2025.